부산대학교 도서관

Blood Advances. 6(16):4735-4735

Petersdorf, EW; Gooley, TA; Malkki, M; Bacigalupo, AP; Cesbron, A; Du, Toit E; Ehninger, G; Egeland, T; Fischer, GF; Gervais, T

BLOOD. 124(26):3996-4003

O'Steen S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington; sosteen@fredhutch.org damiangreen@miami.edu.; Lee SY; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Comstock ML; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Kehret AR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Lin Y; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Hamlin DK; Department of Radiation Oncology, University of Washington, Seattle, Washington.; Dexter SL; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Hippe DS; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and.; Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and.; Wilbur DS; Department of Radiation Oncology, University of Washington, Seattle, Washington.; Li Y; Department of Radiation Oncology, University of Washington, Seattle, Washington.; Walter RB; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and.; School of Medicine, University of Washington, Seattle, Washington.; Till B; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and.; School of Medicine, University of Washington, Seattle, Washington.; Orozco JJ; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; School of Medicine, University of Washington, Seattle, Washington.; Green DJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; and sosteen@fredhutch.org damiangreen@miami.edu.; School of Medicine, University of Washington, Seattle, Washington.

Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

Alam R; University of Washington, Department of Dermatology, Seattle WA, US.; Menon AA; University of Washington, Department of Dermatology, Seattle WA, US.; Ch'en PY; University of Washington, Department of Dermatology, Seattle WA, US; Fred Hutchinson Cancer Center, Clinical Research Division, Seattle WA, US; Albert Einstein College of Medicine, Bronx, NY, US.; Jabbour AJ; University of Washington, Department of Dermatology, Seattle WA, US; New York Medical College, Valhalla, NY; Dermatology Department, NYC Health + Hospital/Metropolitan, New York, NY.; Gooley TA; Fred Hutchinson Cancer Center, Clinical Research Division, Seattle WA, US.; Hippe DS; Fred Hutchinson Cancer Center, Clinical Research Division, Seattle WA, US.; Bhakuni R; University of Washington, Department of Dermatology, Seattle WA, US.; Miller N; Fred Hutchinson Cancer Center, Clinical Research Division, Seattle WA, US.; Lachance K; University of Washington, Department of Dermatology, Seattle WA, US.; Park SY; University of Washington, Department of Dermatology, Seattle WA, US; Fred Hutchinson Cancer Center, Clinical Research Division, Seattle WA, US. Electronic address: songpark@uw.edu.; Nghiem P; University of Washington, Department of Dermatology, Seattle WA, US; Fred Hutchinson Cancer Center, Clinical Research Division, Seattle WA, US. Electronic address: pnghiem@uw.edu.

Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE

Jani S; Department of Dermatology, University of Washington, Seattle, Washington.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.; Bencomo T; Department of Dermatology, University of Washington, Seattle, Washington.; Medical Scientist Training Program, University of Washington, Seattle, Washington.; Shasha C; Vaccine and Infectious Disease Department, Fred Hutchinson Cancer Center, Seattle, Washington.; Pulliam T; Department of Dermatology, University of Washington, Seattle, Washington.; Medical Scientist Training Program, University of Washington, Seattle, Washington.; Jojic A; Vaccine and Infectious Disease Department, Fred Hutchinson Cancer Center, Seattle, Washington.; Church CD; Department of Dermatology, University of Washington, Seattle, Washington.; Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Koelle DM; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.; Vaccine and Infectious Disease Department, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Medicine, University of Washington, Seattle, Washington.; Department of Global Health, University of Washington, Seattle, Washington.; Benaroya Research Institute, Seattle, Washington.; Newell EW; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.; Vaccine and Infectious Disease Department, Fred Hutchinson Cancer Center, Seattle, Washington.; Department of Global Health, University of Washington, Seattle, Washington.; Nghiem P; Department of Dermatology, University of Washington, Seattle, Washington.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Salit RB; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington Medical Center, Seattle, Washington. Electronic address: rsalit@fredhutch.org.; Fan X; Fred Hutchinson Cancer Center, Seattle, Washington.; Gooley TA; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington Medical Center, Seattle, Washington.; Halpern AB; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington Medical Center, Seattle, Washington.; Ratsamee N; Fred Hutchinson Cancer Center, Seattle, Washington.; Marshall A; Fred Hutchinson Cancer Center, Seattle, Washington.; Scott BL; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington Medical Center, Seattle, Washington.; Deeg HJ; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington Medical Center, Seattle, Washington.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Yamada MM; Division of Dermatology, Department of Medicine, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.; Chandrasekhar S; Department of Dermatology, University of Washington, Seattle, Washington, USA.; Gooley TA; Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Chen RE; Division of Dermatology, Department of Medicine, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.; Doolittle-Amieva C; Department of Dermatology, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Ansstas G; Division of Medical Oncology, Department of Medicine, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.; Bhatia S; Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.; Hall ET; Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.; Nghiem PT; Department of Dermatology, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Park SY; Department of Dermatology, University of Washington, Seattle, Washington, USA davidchen@wustl.edu songpark@uw.edu.; Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Chen DY; Division of Dermatology, Department of Medicine, Washington University in St Louis School of Medicine, St Louis, Missouri, USA davidchen@wustl.edu songpark@uw.edu.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Orozco JJ; Division of Hematology/Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.; Translational Science & Therapeutics, Fred Hutchinson Cancer Center, Seattle, Washington.; Matesan MC; Nuclear Medicine, Department of Radiology, University of Washington School of Medicine, Seattle, Washington.; Lundberg SJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Haaf RL; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Miyaoka RS; Nuclear Medicine, Department of Radiology, University of Washington School of Medicine, Seattle, Washington.; Fisher DR; Versant Medical Physics and Radiation Safety, Richland, Washington.; Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Green DJ; Division of Hematology/Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.; Translational Science & Therapeutics, Fred Hutchinson Cancer Center, Seattle, Washington.; Sandmaier BM; Division of Hematology/Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.; Translational Science & Therapeutics, Fred Hutchinson Cancer Center, Seattle, Washington.; Martin PS; Division of Hematology/Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.; Gopal AK; Division of Hematology/Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.

Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

Portuguese AJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Tuazon SA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington; Cell Therapy, Juno Therapeutics, a Bristol Myers Squibb Company, Seattle, Washington.; Pont MJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Translational Sciences, Galapagos NV, Mechelen, Belgium.; Cole GO; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Translational Sciences, Galapagos NV, Mechelen, Belgium.; Sather BD; Cell Therapy, Juno Therapeutics, a Bristol Myers Squibb Company, Seattle, Washington; Research, Tune Therapeutics, Seattle, Washington.; Song X; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Thomas S; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Wood BL; Division of Hematology and Oncology, University of Washington, Seattle, Washington; Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California.; Blake M; Cell Therapy, Juno Therapeutics, a Bristol Myers Squibb Company, Seattle, Washington; Translational Sciences, Sonoma Biotherapeutics, Seattle, Washington.; Works MG; Cell Therapy, Juno Therapeutics, a Bristol Myers Squibb Company, Seattle, Washington; Therapeutic Pipeline, AltPep, Seattle, Washington.; Shadman M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Liang EC; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Wu VQ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Voutsinas JM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Turtle CJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Cancer Immunotherapy, The University of Sydney, Camperdown, New South Wales, Australia; Haematology and Transfusion Medicine, Royal North Shore Hospital, St. Leonards, New South Wales, Australia.; Till BG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Coffey DG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington; Translational Research, Sylvester Comprehensive Cancer Center, Miami, Florida; Division of Transplantation and Cellular Therapy, University of Miami, Miami, Florida.; Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Libby EN; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Chapuis AG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Milano F; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Riddell SR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.; Green DJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington; Translational Research, Sylvester Comprehensive Cancer Center, Miami, Florida; Division of Transplantation and Cellular Therapy, University of Miami, Miami, Florida. Electronic address: damiangreen@miami.edu.; Cowan AJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Division of Hematology and Oncology, University of Washington, Seattle, Washington.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Summers C; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington. Electronic address: corinne.summers@seattlechildrens.org.; Mallhi K; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington.; Persinger H; Fred Hutchinson Cancer Center, Seattle, Washington.; Fan X; Fred Hutchinson Cancer Center, Seattle, Washington.; Gooley TA; Fred Hutchinson Cancer Center, Seattle, Washington.; Dahlberg AE; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington.; Burroughs LM; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington.; Thakar MS; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington.; Bhatt NS; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington.; Petrovic A; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington.; Hadland B; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington.; Carpenter PA; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington.; Baker KS; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington.; Bleakley M; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington.

Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE

Kopmar NE; Division of Hematology & Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Qu X; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Liu Y; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Ghiuzeli CM; Division of Hematology & Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Mawad R; Division of Hematology & Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Percival MM; Division of Hematology & Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Fang M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; Cassaday RD; Division of Hematology & Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process

Back AL; Departments of Medicine and Psychiatry, University of Washington School of Medicine, Seattle.; Freeman-Young TK; Departments of Medicine and Psychiatry, University of Washington School of Medicine, Seattle.; Morgan L; Departments of Medicine and Psychiatry, University of Washington, Seattle.; Sethi T; Departments of Medicine and Psychiatry, University of Washington School of Medicine, Seattle.; Baker KK; Fred Hutchinson Cancer Center, Seattle, Washington.; Myers S; Fred Hutchinson Cancer Center, Seattle, Washington.; McGregor BA; Orion Center for Integrative Medicine, Seattle, Washington.; Harvey K; Quantified Citizen, Vancouver, British Columbia, Canada.; Tai M; Departments of Medicine and Psychiatry, University of Washington School of Medicine, Seattle.; Kollefrath A; Departments of Medicine and Psychiatry, University of Washington School of Medicine, Seattle.; Thomas BJ; Departments of Medicine and Psychiatry, University of Washington School of Medicine, Seattle.; Sorta D; Psychiatric Alternatives and Wellness Center, San Francisco, California.; Kaelen M; Wavepaths Ltd, London, United Kingdom.; Kelmendi B; Yale School of Medicine, New Haven, Connecticut.; Gooley TA; Fred Hutchinson Cancer Center, Seattle, Washington.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Richardson AB; University of Washington Medical Center, Seattle, Washington.; Ng K; Fred Hutchinson Cancer Center, Seattle, Washington.; Gooley TA; University of Washington Medical Center, Seattle, Washington; Fred Hutchinson Cancer Center, Seattle, Washington.; Cheng GS; University of Washington Medical Center, Seattle, Washington; Fred Hutchinson Cancer Center, Seattle, Washington.; Salit RB; University of Washington Medical Center, Seattle, Washington; Fred Hutchinson Cancer Center, Seattle, Washington. Electronic address: rsalit@fredhutch.org.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Tuazon SA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Cell Therapy, Juno Therapeutics, a Bristol Myers Squibb Company, Seattle, WA.; Portuguese AJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Pont MJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Cowan AJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Cole GO; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Sather BD; Department of Cell Therapy, Juno Therapeutics, a Bristol Myers Squibb Company, Seattle, WA.; Song X; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Thomas S; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Wood BL; Hematopathology Division, University of Washington, Seattle, WA.; Blake M; Department of Cell Therapy, Juno Therapeutics, a Bristol Myers Squibb Company, Seattle, WA.; Works MG; Department of Cell Therapy, Juno Therapeutics, a Bristol Myers Squibb Company, Seattle, WA.; Shadman M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Liang EC; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Wu QV; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Voutsinas JM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Turtle CJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Till BG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Coffey DG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Division of Myeloma, Department of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL.; Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Riddell SR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Green DJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Myeloma, Department of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL.; Division of Transplantation and Cellular Therapy, Department of Medicine, University of Miami, Miami, FL.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Bovee LB; Division of Metabolism, Endocrinology, and Nutrition, University of Washington School of Medicine, Seattle, Washington, USA.; Gooley TA; Clinician Research Division, Fred Hutch Cancer Center, Seattle, Washington, USA.; Perlman JE; Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Hirsch IB; Division of Metabolism, Endocrinology, and Nutrition, University of Washington School of Medicine, Seattle, Washington, USA.

Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8593 (Electronic) Linking ISSN: 15209156 NLM ISO Abbreviation: Diabetes Technol Ther Subsets: MEDLINE

Samples L; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Sadrzadeh H; Section of Hematology and Medical Oncology, Boston University Medical Center, Boston, MA.; Frigault MJ; Center for Cellular Immunotherapy, Massachusetts General Hospital, Boston, MA.; Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Hamadani M; Blood and Marrow Transplant and Cellular Therapy, Medical College of Wisconsin, Milwaukee, WI.; Gurumurthi A; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Medical Center, Houston, TX.; Strati P; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Medical Center, Houston, TX.; Shouval R; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.; Noy A; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.; Riedell PA; Section of Hematology and Oncology, University of Chicago Medical Center, Chicago, IL.; Dahiya S; Blood and Marrow Transplantation and Cellular Therapy, Stanford Cancer Center, Stanford, CA.; Maloney DG; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Till BG; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Hirayama AV; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Gauthier J; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Gopal AK; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Smith SD; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Poh C; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Lynch R; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Ujjani C; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Di M; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Raghunathan V; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Shakib-Azar M; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Naresh KN; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.; Gooley TA; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Yared J; Division of Hematology/Oncology, University of Maryland, Baltimore, MD.; Jain MD; Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.; Locke FL; Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.; Leslie LA; Division of Lymphoma, John Theurer Cancer Center, Hackensack, NJ.; Epperla N; Division of Hematology, The Ohio State University, Columbus, OH.; Ghosh M; Bone Marrow Transplant and Leukemia, University of Michigan, Ann Arbor, MI.; Skarbnik A; Department of Hematology, Novant Health Cancer Institute, Charlotte, NC.; Hill BT; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH.; Kamdar MK; Division of Hematology, University of Colorado Hospital, Aurora, CO.; Ortiz-Maldonado V; Oncoimmunotherapy Unit, Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Martinez-Cibrian N; Oncoimmunotherapy Unit, Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Shune L; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Kansas City, KS.; Shadman M; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington, Seattle, WA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Pan, L. ; Yang, S.

In Annals of the Rheumatic Diseases June 2024 83 Supplement 1:1988-1988

Boiko JR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Pediatrics, University of Washington, Seattle, WA.; Ensbey KS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Waltner OG; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Jenkins IC; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Bhise SS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; MacDonald KPA; Department of Infection and Inflammation, Queensland Institute of Medical Research Berghofer, Brisbane, Australia.; Blazar BR; Division of Blood and Marrow Transplant and Cellular Therapy, Department of Pediatrics, University of Minnesota, Minneapolis, MN.; Hall AM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Minnie SA; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Lee SJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.; Furlan SN; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Pediatrics, University of Washington, Seattle, WA.; Hill GR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Raychaudhuri S; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Rasmussen A; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Quach K; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Gill E; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Halpern AB; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Appelbaum JS; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Ghiuzeli CM; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Hendrie PC; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Cassaday RD; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Walter RB; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.; Percival MM; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.

Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE

Levine KM; University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Uy NF; University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Gooley TA; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Voutsinas J; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Tratt M; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Eaton KD; University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Santana-Davila R; University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Berger AH; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Baik CS; University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA. Electronic address: cbaik2@uw.edu.

Publisher: Elsevier Country of Publication: England NLM ID: 101694651 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-2942 (Electronic) Linking ISSN: 24682942 NLM ISO Abbreviation: Cancer Treat Res Commun Subsets: MEDLINE